CureVac

Yahoo Finance • last month

CureVac NV earnings missed by €0.21, revenue fell short of estimates

Investing.com - CureVac NV (NASDAQ: CVAC) reported second quarter EPS of €-0.260, €0.21 worse than the analyst estimate of €-0.046. Revenue for the quarter came in at €1.25M versus the consensus estimate of €34.59M. CureVac NV’s stock pri... Full story

Yahoo Finance • last month

CureVac BV reports Q2 results

* CureVac BV press release [https://seekingalpha.com/pr/20202438-curevac-announces-financial-results-for-the-second-quarter-and-first-half-of-2025-and] (NASDAQ:CVAC [https://seekingalpha.com/symbol/CVAC]): Q2 Revenues amounted to €1.2 mi... Full story

Yahoo Finance • 2 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

BioNTech SE Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific antibody candidate targeting PD... Full story

Yahoo Finance • 3 months ago

CureVac N.V. (CVAC) Has Gained Over 16% In One Month. Here Is Why

CureVac N.V. (NASDAQ:CVAC) is among the 13 Best German Stocks to Invest in Now. The stock has gained by over 16% in the past month, with a major surge following the June 12 announcement that the company had agreed to be acquired by BioNTec... Full story

Yahoo Finance • 3 months ago

Deutsche Bank bearish on European pharma stocks into Q2 amid political headwinds

Investing.com -- Deutsche Bank has made several rating and target price adjustments across the European pharmaceuticals space ahead of second-quarter earnings, flagging continued weakness in the sector and potential opportunities in select... Full story

Yahoo Finance • 3 months ago

CureVac stock downgraded to neutral by UBS after BioNTech acquisition

Investing.com - UBS downgraded CureVac (NASDAQ:CVAC) from Buy to Neutral on Thursday, lowering its price target to $5.50 from $12.00 following the company’s acquisition by BioNTech (NASDAQ:BNTX). According to InvestingPro data, CureVac mai... Full story

Yahoo Finance • 3 months ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 3 months ago

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CureVac N.V. (NASDAQ: CVAC)

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the... Full story

Yahoo Finance • 3 months ago

Notable healthcare headlines for the week: Novo Nordisk, Thermo Fisher and UnitedHealth in focus

Wall Street's major averages plummeted on Friday after Israel and Iran traded missile strikes and stoked concerns of an all-out war in the Middle East. Iran retaliated on Friday with its own projectiles after Israel’s attack on some of Ir... Full story

Yahoo Finance • 3 months ago

Key deals this week: BioNTech, UnitedHealth, Qualcomm, Papa John's and more

[Top view of business office workstation with M&A letters or merger and acquisition] Atstock Productions Here's a list of key deals reported across sectors this week: BioNTech (NASDAQ:BNTX [https://seekingalpha.com/symbol/BNTX]) has agre... Full story

Yahoo Finance • 3 months ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 3 months ago

Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz

The major averages were mixed near noon with the Dow the laggard as a pullback in Boeing weighs on the Industrials index. U.S. initial jobless claims were unchanged at 248,000 in the week ended June 7, above expectations and holding at an... Full story

Yahoo Finance • 3 months ago

Top Midday Stories: Boeing Shares Fall After Air India Plane Crash; Oracle Q4 Results Top Expectations

Wall Street's major market averages were mixed around midday Thursday after President Donald Trump's PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Stocks to Watch Thursday: Boeing, Oracle, Oklo, CureVac

↘️ Boeing (BA): A Boeing 787-8 jet crashed in the Indian city of Ahmedabad. Authorities say it is likely all 242 passengers were killed. Shares dropped 5% early Thursday. 🎧 Listen here. ↗️ Oracle (ORCL): The cloud-services company logged... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest premarket moves: Boeing, Oracle, GameStop, Voyager Technologies and more

Check out the companies making the biggest moves in premarket trading: Boeing –The airplane maker lost 7.5% following the crash of an Air India Boeing Dreamliner Thursday. The plane, carrying 242 passengers and crew, crashed shortly after... Full story

Yahoo Finance • 3 months ago

BioNTech To Acquire CureVac In All-stock Deal With Aggregate Equity Value Of Approx. $1.25 Bln

(RTTNews) - BioNTech SE (BNTX) and CureVac N.V. (CVAC) have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing medicines in o... Full story

Yahoo Finance • 3 months ago

BioNTech to buy German rival CureVac for $1.25B in all-stock deal

BioNTech (NASDAQ:BNTX [https://seekingalpha.com/symbol/BNTX]) has agreed to acquire its German rival CureVac (NASDAQ:CVAC [https://seekingalpha.com/symbol/CVAC]) in an all-stock transaction worth nearly $1.25B, the companies announced Thur... Full story

Yahoo Finance • 3 months ago

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy Acquisition of CureVa... Full story

Yahoo Finance • 3 months ago

BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an

Die geplante Übernahme soll die Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist ein weiterer wichtiger Meilenstein in der Umsetzung von BioNTechs Onkologie-Strateg... Full story

Yahoo Finance • last year

GSK plc (GSK): Why Are Hedge Funds Bullish on This Undervalued UK Stock Now?

We recently compiled a list of the 10 Best Undervalued UK Stocks To Buy Now.In this article, we are going to take a look at where GSK plc (LON:GSK) stands against the other undervalued UK stocks. The Economy of the United Kingdom Accordi... Full story